Applied BioSciences Corp. (APPB) Financial Statements (2026 and earlier)

Company Profile

Business Address 9701 WILSHIRE BLVD.
BEVERLY HILLS, CA 90212
State of Incorp.
Fiscal Year End March 31
Industry (SIC) 204 - Grain Mill Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments612132 
Cash and cash equivalent612132 
Receivables126  
Inventory, net of allowances, customer advances and progress billings2923  
Inventory2923  
Prepaid expense12417  
Total current assets:2272582 
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization4   
Long-term investments and receivables469300  
Long-term investments469300  
Intangible asset, including goodwill, after accumulated amortization 1,118  
Goodwill    
Intangible asset, excluding goodwill, after accumulated amortization  1,118  
Other noncurrent assets6   
Total noncurrent assets:4781,418  
TOTAL ASSETS:7051,6762 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:22202
Accounts payable221202
Other undisclosed accounts payable and accrued liabilities  (10)  
Due to related parties  194111
Other undisclosed current liabilities1410  
Total current liabilities:36324113
Noncurrent Liabilities
Other undisclosed noncurrent liabilities (9)2  
Total noncurrent liabilities: (9)2  
Total liabilities:27334113
Equity
Equity, attributable to parent, including:6691,645(39)(13)
Common stock001002,590
Common stock, value, subscriptions  375 3
Additional paid in capital3,0541,742(92)(2,585)
Accumulated deficit(2,902)(526)(47)(18)
Other undisclosed equity, attributable to parent51753 (3)
Equity, attributable to noncontrolling interest    
Other undisclosed equity 9(2)  
Total equity:6781,643(39)(13)
TOTAL LIABILITIES AND EQUITY:7051,6762 

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Revenues19846  
Revenue, net✕19846  
Cost of revenue(156)(6)  
Gross profit:4239  
Operating expenses(2,429)(555)(28)(17)
Other undisclosed operating income 3871,040  
Operating income (loss):(2,000)524(28)(17)
Nonoperating expense
(Other Nonoperating expense)		    
Interest and debt expense    
Income (loss) from continuing operations:(2,000)524(28)(17)
Income (loss) before gain (loss) on sale of properties:(2,000)524(28)(17)
Other undisclosed net income (loss)(376)(1,042)  
Net loss:(2,376)(518)(28)(17)
Net income (loss) attributable to noncontrolling interest11(2)  
Other undisclosed net income (loss) attributable to parent(22)3  
Net loss available to common stockholders, diluted:(2,387)(516)(28)(17)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Net loss:(2,376)(518)(28)(17)
Comprehensive loss:(2,376)(518)(28)(17)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest11(2)  
Comprehensive loss, net of tax, attributable to parent:(2,365)(519)(28)(17)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: